Market Trends of Sciatica Industry
The Non-Steroidal Anti Inflammatory Drug Segment is Expected to Witness a Strong Growth
The main antiinflammatory, antipyretic, and analgesic effect of NSAIDs is based on the suppression of the cyclooxygenase (COX)1 and COX2 enzymes. By blocking the COX enzymes, vasodilation is reduced and inflammation relieved. Non-steroidal antiinflammatory drugs (NSAIDs) are one of the most frequently prescribed drugs for the treatment of sciatica. The products are getting approvals and hence, creating lucrative opportunities in the market. As per sciaticapain.co.uk, 2022, painkillers stop the production of these cells, and the brain stops signaling that there is pain somewhere in the body.
Pain killers and anti-inflammatory medicines are the most effective medicines that make up the most numerous group of drugs. Most commonly, antirheumatics (painkillers) are used to treat pain, fever, muscle pain, and other musculoskeletal disorders. Doctors recommend low-dose medications that can be purchased over the counter, such as Ibuprofen or Tylenol. The over-the-counter NSAIDs are meant to provide pain relief. Prescription NSAIDs may be necessary for pain relief if over-the-counter drugs are ineffective. Therefore, with the significance of NSAIDs in coping with sciatica, the segment is expected to grow significantly in the forecast period.
North America is Expected to Hold a Significant Share in the Market
North America is expected to hold a major market share in the global Sciatica market due to the rise in the geriatric population and the increasing prevalence of lower back pain in this region. As per a study published by National Center for Health Statistics, in 2021, around 39% of adults in the United States stated they had experienced back pain within the past three months. A greater number of orthopedic procedures due to greater healthcare penetration in the United States and Canada drives the sciatica market.
Further, the increasing geriatric population of the region is expected to have a significant impact on the growth of the studied market as the older population is more prone to pain and other musculoskeletal disorders. For instance, according to the 2021 report of the United States Census Bureau, more than 54 million people of age 65 years and above were living in the country during 2021 and this number is projected to reach 85.7 million by 2050, which will be about 20% of the total population of the United States. As old people are prone to develop sciatica, the market studied is expected to grow as a result of the geriatric population increase.
Moreover, high expenditure on healthcare, especially in the United States and Canada, along with increased awareness about the disease, are fueling the growth of the overall regional market to a large extent. Therefore, due to the aforementioned factors, the North American region is expected to hold a significant share of the sciatica market over the forecast period.
